Consolidated Statements Of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 767,823,000		$ 1,760,033,000		$ 1,059,704,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	303,446,000		242,868,000		159,707,000
Earnings of equity method investments, net of distributions	5,198,000		701,000		387,000
Loss on early extinguishment of debt attributable to unamortized discount	7,948,000		0		0
Gain on sale of marketable equity securities	0		(326,000)		0
Deferred income taxes	114,404,000		95,408,000		(8,860,000)
Equity-based compensation expense	35,775,000		39,203,000		26,825,000
Change in fair value – derivative instruments	(53,185,000)		52,335,000		306,000
Loss on settlement of retirement benefit obligations, net of contributions	16,771,000		(19,524,000)		(6,049,000)
(Increase) decrease in current assets:
Accounts receivable	(68,832,000)		71,627,000		373,591,000
Inventories	(15,929,000)		(205,013,000)		(56,828,000)
Income taxes receivable	(34,419,000)		19,056,000		(36,394,000)
Prepayments and other	1,377,000		(9,366,000)		(14,214,000)
Increase (decrease) in current liabilities:
Accounts payable	2,068,000		(194,051,000)		(251,428,000)
Income taxes payable	0		(40,366,000)		72,091,000
Accrued liabilities	(41,229,000)		(39,851,000)		60,467,000
Turnaround expenditures	(193,920,000)		(159,707,000)		(32,023,000)
Other, net	21,878,000		49,660,000		(8,891,000)
Net cash provided by operating activities	869,174,000	[1]	1,662,687,000	[1]	1,338,391,000	[1]
Cash flows from investing activities:
Additions to properties, plants and equipment	(373,271,000)		(290,334,000)		(158,026,000)
Acquisition of trucking operations	(11,301,000)		0		0
Proceeds from sale of property and equipment	7,802,000		0		0
Increase in cash due to merger with Frontier	0		0		872,739,000
Investment in Sabine Biofuels	(3,000,000)		(2,000,000)		(9,125,000)
Net advances to Sabine Biofuels	(5,740,000)		0		0
Purchases of marketable securities	(935,512,000)		(671,552,000)		(561,899,000)
Sales and maturities of marketable securities	846,143,000		297,711,000		301,020,000
Net cash provided by (used for) investing activities	(526,735,000)		(711,104,000)		228,494,000
Cash flows from financing activities:
Redemption of senior notes - HFC	(300,973,000)		(205,000,000)		(8,203,000)
Proceeds from sale of HEP common units	73,444,000		0		0
Purchase of treasury stock	(225,023,000)		(209,600,000)		(42,795,000)
Structured stock repurchase arrangement	0		8,620,000		0
Contribution from joint venture partner	0		6,000,000		33,500,000
Dividends	(645,920,000)		(658,085,000)		(252,133,000)
Distributions to noncontrolling interest	(71,201,000)		(58,788,000)		(50,874,000)
Excess tax benefit from equity-based compensation	2,562,000		23,361,000		1,804,000
Deferred financing costs and other	(3,055,000)		(4,806,000)		(13,555,000)
Net cash used for financing activities	(1,160,035,000)		(772,788,000)		(217,082,000)
Cash and cash equivalents:
Increase (decrease) for the period	(817,596,000)		178,795,000		1,349,803,000
Beginning of period	1,757,699,000		1,578,904,000		229,101,000
End of period	940,103,000		1,757,699,000		1,578,904,000
Cash paid during the period for:
Interest	76,647,000		101,709,000		78,483,000
Income taxes	372,846,000		983,618,000		552,487,000
HEP
Cash flows from investing activities:
Additions to properties, plants and equipment	(51,856,000)		(44,929,000)		(216,215,000)
Proceeds from sale of property and equipment	7,802,000
Cash flows from financing activities:
Borrowings under credit agreement – HEP	310,600,000		587,000,000		118,000,000
Repayments under credit agreement – HEP	(368,600,000)		(366,000,000)		(77,000,000)
Net proceeds from issuance of senior notes – HEP	0		294,750,000		0
Redemption of senior notes - HFC			(205,000,000)		(8,203,000)
Redemption of senior notes	0		(185,000,000)		0
Proceeds from common unit offerings – HEP	73,444,000		0		75,815,000
Contribution from joint venture partner					33,500,000
Distributions to noncontrolling interest	(71,201,000)		(58,788,000)		(50,874,000)
Purchase of units for incentive grants – HEP	(5,313,000)		(5,240,000)		(1,641,000)
Cash and cash equivalents:
Beginning of period	5,237,000
End of period	$ 6,352,000		$ 5,237,000

[1] Parent operating cash flows includes cash inflows of $806.0 million, $2,727.6 million and $2,147.0 million for the years ended December 31, 2013, 2012 and 2011, respectively, representing distributions of earnings from the Restricted Subsidiaries.